Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Bosutinib |
Trade Name | Bosulif |
Synonyms | SKI-606|PF-5208763 |
Drug Descriptions |
Bosulif (bosutinib) inhibits SRC and ABL kinases, and has additional activity against other kinases including AXL, TNK2, BTK, resulting in decreased pathway activation and inhibition of tumor cell proliferation (PMID: 12543790, PMID: 19039322, PMID: 26555154). Bosulif (bosutinib) is FDA approved for use in patients with Ph+ (BCR-ABL) chronic myelogenous leukemia (FDA.gov). |
DrugClasses | ABL Inhibitor (pan) 9 AXL Inhibitor 28 BCR-ABL Inhibitor 29 BTK inhibitor 32 SRC Inhibitor 31 TNK2 Inhibitor 6 |
CAS Registry Number | 380843-75-4 |
NCIT ID | C60809 |